UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN C000000322
Receipt number R000000415
Scientific Title Randomized Phase II Study of Docetaxel (T) with or without Capecitabine (X) as Neoadjuvant Chemotherapy in Female Patients with Operable Breast Cancer Who were not Observed Disease Progression after 4 cycles of 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) (OOTR N003)
Date of disclosure of the study information 2006/02/10
Last modified on 2018/03/15 11:30:18

No. Disposal Last modified on Item of update
1 Insert 2006/02/03 17:38:49
2 Update 2006/02/03 17:40:49 UMIN ID1
3 Update 2006/02/04 12:46:14 UMIN ID2
4 Update 2006/02/04 13:04:28 Last name of lead principal investigator
Organization
Organization
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
5 Update 2009/05/29 14:08:30 Key inclusion criteria
Key inclusion criteria
6 Update 2009/05/29 14:22:27 Last name of lead principal investigator
Organization
Organization
Address
Nationality of Funding Organization
Nationality of Funding Organization
7 Update 2009/05/29 14:32:52 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
8 Update 2011/02/25 14:03:19 Recruitment status
9 Update 2018/03/12 10:43:35 Last name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Email
Organization
Organization
Address
Address
Email
Name of primary person or sponsor
Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.
10 Update 2018/03/15 11:30:18 Organization
Organization
Division name
Division name
Address
Address
TEL
Organization
Organization
Division name
Division name
Address
Address
TEL